piperacillin--tazobactam-drug-combination has been researched along with Hematoma* in 2 studies
2 other study(ies) available for piperacillin--tazobactam-drug-combination and Hematoma
| Article | Year |
|---|---|
Prolonged treatment of COVID-19 pneumonia with high-flow nasal oxygen: A story of oxygen and resilience.
The COVID-19 pandemic has placed significant strain on the oxygen delivery infrastructure of health facilities in resource-constrained health systems. In this case report, we describe a patient with severe COVID-19 pneumonia who was managed with high-flow nasal oxygen for 40 days, with an eventual successful outcome. We discuss the oxygen delivery infrastructure needed to offer this intervention, as well as the psychosocial impact on those undergoing treatment. Topics: Anti-Bacterial Agents; Anticoagulants; Anxiety; Blood Gas Analysis; Cannula; Citalopram; Counseling; COVID-19; Dexamethasone; Disease Progression; Enoxaparin; Factor Xa Inhibitors; Female; Glucocorticoids; Healthcare-Associated Pneumonia; Hematoma; Humans; Hypoxia; Middle Aged; Oxygen; Oxygen Inhalation Therapy; Patient Care Team; Patient Positioning; Piperacillin, Tazobactam Drug Combination; Prone Position; Psychiatry; Psychosocial Support Systems; Resilience, Psychological; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Social Work Department, Hospital; Thigh; Treatment Outcome | 2020 |
Empyema necessitatis following chest trauma.
Topics: Abscess; Anti-Bacterial Agents; Debridement; Diabetes Mellitus, Type 2; Disease Susceptibility; Empyema, Pleural; Hematoma; Humans; Male; Middle Aged; Obesity, Morbid; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pleural Effusion; Smoking; Streptococcal Infections; Streptococcus agalactiae; Thoracic Injuries; Wound Infection; Wounds, Nonpenetrating | 2014 |